Cargando…

The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome

OBJECTIVE: Hyperandrogenaemia and insulin resistance (IR) are the main characteristics of polycystic ovary syndrome (PCOS). Here, we study to find appropriate markers predicting IR and hyperandrogenaemia of women with PCOS in northwest China. METHODS: According to body mass index (BMI), 953 patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haiyan, Cao, Haozhe, Cao, Jing, Zhang, Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940946/
https://www.ncbi.nlm.nih.gov/pubmed/36814799
http://dx.doi.org/10.1155/2023/1508675
_version_ 1784891178836033536
author Wang, Haiyan
Cao, Haozhe
Cao, Jing
Zhang, Li
author_facet Wang, Haiyan
Cao, Haozhe
Cao, Jing
Zhang, Li
author_sort Wang, Haiyan
collection PubMed
description OBJECTIVE: Hyperandrogenaemia and insulin resistance (IR) are the main characteristics of polycystic ovary syndrome (PCOS). Here, we study to find appropriate markers predicting IR and hyperandrogenaemia of women with PCOS in northwest China. METHODS: According to body mass index (BMI), 953 patients with PCOS were divided into two groups. All the patients underwent physical examination and ultrasonography and collected elbow vein blood. Their BMI, waist-to-height ratio (WHtR), waist-to-hip ratio (WHR), LAP, VAI, homeostasis model assessment index of insulin resistance (HOMA-IR), and free androgen index (FAI) were calculated. Each group (normal weight and obesity/overweight) was further divided into two subgroups according to their HOMA-IR and FAI: the IR+ subgroup/IR- subgroup and FAI+ subgroup/FAI- subgroup. Furthermore, we compared the clinical indices, hormone levels, and metabolic makers separately between these groups. The correlations between these parameters and HOMA-IR or FAI were tested; sensitivity, specificity, and receiver-operating characteristic (ROC) curves were calculated. RESULTS: In the obesity/overweight group, the VAI (best cut-off value: 2.27, area under the curve (AUC) = 0.699) and LAP (best cut-off value: 45.54, AUC = 0.680) were sensitive predictors of IR (sensitivity = 72% and sensitivity = 67%). Additionally, the VAI (best cut-off value: 2.13, AUC = 0.624) and LAP (best cut-off value: 51.18, AUC = 0.582) were sensitive predictors of FAI (sensitivity = 87% and sensitivity = 64%). In the normal weight group, BMI could preferably predict HOMA-IR (AUC = 0.717, best cut-off value: 21.62) and HOMA-IR could preferably predict FAI (best cut-off value: 2.11, AUC = 0.648). CONCLUSION: Our data indicated that the VAI and LAP may contribute to the early identification of IR and hyperandrogenaemia in the obesity/overweight patients of PCOS. In normal weight PCOS, BMI was a better predictor to IR, and HOWA-IR was a better predictor to FAI.
format Online
Article
Text
id pubmed-9940946
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Hindawi
record_format MEDLINE/PubMed
spelling pubmed-99409462023-02-21 The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome Wang, Haiyan Cao, Haozhe Cao, Jing Zhang, Li Biomed Res Int Research Article OBJECTIVE: Hyperandrogenaemia and insulin resistance (IR) are the main characteristics of polycystic ovary syndrome (PCOS). Here, we study to find appropriate markers predicting IR and hyperandrogenaemia of women with PCOS in northwest China. METHODS: According to body mass index (BMI), 953 patients with PCOS were divided into two groups. All the patients underwent physical examination and ultrasonography and collected elbow vein blood. Their BMI, waist-to-height ratio (WHtR), waist-to-hip ratio (WHR), LAP, VAI, homeostasis model assessment index of insulin resistance (HOMA-IR), and free androgen index (FAI) were calculated. Each group (normal weight and obesity/overweight) was further divided into two subgroups according to their HOMA-IR and FAI: the IR+ subgroup/IR- subgroup and FAI+ subgroup/FAI- subgroup. Furthermore, we compared the clinical indices, hormone levels, and metabolic makers separately between these groups. The correlations between these parameters and HOMA-IR or FAI were tested; sensitivity, specificity, and receiver-operating characteristic (ROC) curves were calculated. RESULTS: In the obesity/overweight group, the VAI (best cut-off value: 2.27, area under the curve (AUC) = 0.699) and LAP (best cut-off value: 45.54, AUC = 0.680) were sensitive predictors of IR (sensitivity = 72% and sensitivity = 67%). Additionally, the VAI (best cut-off value: 2.13, AUC = 0.624) and LAP (best cut-off value: 51.18, AUC = 0.582) were sensitive predictors of FAI (sensitivity = 87% and sensitivity = 64%). In the normal weight group, BMI could preferably predict HOMA-IR (AUC = 0.717, best cut-off value: 21.62) and HOMA-IR could preferably predict FAI (best cut-off value: 2.11, AUC = 0.648). CONCLUSION: Our data indicated that the VAI and LAP may contribute to the early identification of IR and hyperandrogenaemia in the obesity/overweight patients of PCOS. In normal weight PCOS, BMI was a better predictor to IR, and HOWA-IR was a better predictor to FAI. Hindawi 2023-02-13 /pmc/articles/PMC9940946/ /pubmed/36814799 http://dx.doi.org/10.1155/2023/1508675 Text en Copyright © 2023 Haiyan Wang et al. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Wang, Haiyan
Cao, Haozhe
Cao, Jing
Zhang, Li
The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome
title The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome
title_full The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome
title_fullStr The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome
title_full_unstemmed The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome
title_short The Visceral Adiposity Index (VAI) and Lipid Accumulation Product (LAP) Are Predictors of Insulin Resistance and Hyperandrogenaemia in Obesity/Overweight Women with Polycystic Ovary Syndrome
title_sort visceral adiposity index (vai) and lipid accumulation product (lap) are predictors of insulin resistance and hyperandrogenaemia in obesity/overweight women with polycystic ovary syndrome
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940946/
https://www.ncbi.nlm.nih.gov/pubmed/36814799
http://dx.doi.org/10.1155/2023/1508675
work_keys_str_mv AT wanghaiyan thevisceraladiposityindexvaiandlipidaccumulationproductlaparepredictorsofinsulinresistanceandhyperandrogenaemiainobesityoverweightwomenwithpolycysticovarysyndrome
AT caohaozhe thevisceraladiposityindexvaiandlipidaccumulationproductlaparepredictorsofinsulinresistanceandhyperandrogenaemiainobesityoverweightwomenwithpolycysticovarysyndrome
AT caojing thevisceraladiposityindexvaiandlipidaccumulationproductlaparepredictorsofinsulinresistanceandhyperandrogenaemiainobesityoverweightwomenwithpolycysticovarysyndrome
AT zhangli thevisceraladiposityindexvaiandlipidaccumulationproductlaparepredictorsofinsulinresistanceandhyperandrogenaemiainobesityoverweightwomenwithpolycysticovarysyndrome
AT wanghaiyan visceraladiposityindexvaiandlipidaccumulationproductlaparepredictorsofinsulinresistanceandhyperandrogenaemiainobesityoverweightwomenwithpolycysticovarysyndrome
AT caohaozhe visceraladiposityindexvaiandlipidaccumulationproductlaparepredictorsofinsulinresistanceandhyperandrogenaemiainobesityoverweightwomenwithpolycysticovarysyndrome
AT caojing visceraladiposityindexvaiandlipidaccumulationproductlaparepredictorsofinsulinresistanceandhyperandrogenaemiainobesityoverweightwomenwithpolycysticovarysyndrome
AT zhangli visceraladiposityindexvaiandlipidaccumulationproductlaparepredictorsofinsulinresistanceandhyperandrogenaemiainobesityoverweightwomenwithpolycysticovarysyndrome